These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 74729)
1. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors. Riegger AJ; Lever AF; Millar JA; Morton JJ; Slack B Lancet; 1977 Dec 24-31; 2(8052-8053):1317-9. PubMed ID: 74729 [TBL] [Abstract][Full Text] [Related]
2. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF; Russell GI; Swales JD; Thurston H J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor. Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin). Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition. Atkinson AB; Brown JJ; Fraser R; Lever AF; Morton JJ; Riegger AJ; Robertson JI Clin Exp Hypertens (1978); 1980; 2(3-4):499-524. PubMed ID: 6253241 [TBL] [Abstract][Full Text] [Related]
6. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903 [TBL] [Abstract][Full Text] [Related]
7. Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat. Thurston H; Bing RF; Marks ES; Swales JD Clin Sci (Lond); 1980 Jan; 58(1):15-20. PubMed ID: 6986225 [TBL] [Abstract][Full Text] [Related]
9. Detection of renovascular hypertension with angiotensin II blockade. Baer L; Parra-Carrilo JZ; Radichevich I; Williams GS Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983 [TBL] [Abstract][Full Text] [Related]
10. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects. Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403 [TBL] [Abstract][Full Text] [Related]
11. [Use of saralasin in hypertensive uremic patients under periodic hemodialysis treatment]. Cappelli G; Vagge R; Lamperi S Minerva Nefrol; 1979; 26(1):5-8. PubMed ID: 471322 [No Abstract] [Full Text] [Related]
12. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat. Macdonald GJ; Boyd GW; Peart WS Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561 [TBL] [Abstract][Full Text] [Related]
13. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor. Case DB; Laragh JH Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension. Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP Circulation; 1980 May; 61(5):920-4. PubMed ID: 6988103 [TBL] [Abstract][Full Text] [Related]
15. Effects of saralasin infusion on bilateral renal function in two-kidney, one-clip Goldblatt hypertensive rats. Huang WC; Ploth DW; Navar LG Clin Sci (Lond); 1982 Jun; 62(6):573-9. PubMed ID: 7083749 [TBL] [Abstract][Full Text] [Related]
16. [Arterial hypertension and maintenance hemodialysis: effects of specific inhibition of angiotensin II by saralasin acetate]. Mimran A; Deschodt G; Shaldon S; Barjon P; Mion C Arch Mal Coeur Vaiss; 1978 Jul; 71 Spec No():19-24. PubMed ID: 101176 [TBL] [Abstract][Full Text] [Related]
17. Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion. DeQuattro V; Barbour BH; Campese V; Finck EJ; Miano L; Esler M Mayo Clin Proc; 1977 Jun; 52(6):369-73. PubMed ID: 865132 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor. Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956 [TBL] [Abstract][Full Text] [Related]
19. Prolongation of the saralasin responsive state of two-kidney, one clip Goldblatt hypertension in the rat by the orally administered converting enzyme inhibitor captopril (SQ14,225). Weed WC; Vaughan ED; Peach MJ Hypertension; 1979; 1(1):8-12. PubMed ID: 397195 [TBL] [Abstract][Full Text] [Related]
20. The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery. Romero JC; Holmes DR; Strong CG Circ Res; 1977 May; 40(5 Suppl 1):I17-23. PubMed ID: 870227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]